Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Liver Fat ◽

Effect of Dulaglutide on Liver Fat in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial (D-LIFT Trial)

SSRN Electronic Journal ◽

10.2139/ssrn.3582791 ◽

2020 ◽

Author(s):

Mohammad Kuchay ◽

Sonal Krishan ◽

Sunil Kumar Mishra ◽

Narendra Singh Choudhary ◽

Manish Kumar Singh ◽

...

Keyword(s):

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Liver Fat ◽

Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial

Diabetes Care ◽

10.2337/dc14-2852 ◽

2015 ◽

Vol 38 (7) ◽

pp. 1245-1252 ◽

Cited By ~ 24

Author(s):

Ji Cheol Bae ◽

Won Young Lee ◽

Kun Ho Yoon ◽

Joong Yeol Park ◽

Hyun Sik Son ◽

...

Keyword(s):

Type 2 Diabetes ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial

Journal of Hepato-Biliary-Pancreatic Sciences ◽

10.1002/jhbp.318 ◽

2016 ◽

Vol 23 (3) ◽

pp. 167-173 ◽

Cited By ~ 4

Author(s):

Sohei Satoi ◽

Masayuki Sho ◽

Hiroaki Yanagimoto ◽

Tomohisa Yamamoto ◽

Takahiro Akahori ◽

...

Keyword(s):

Pancreatic Cancer ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Protective Role ◽

Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

Clinical Drug Investigation ◽

10.1007/s40261-019-00785-6 ◽

2019 ◽

Vol 39 (7) ◽

pp. 631-641 ◽

Cited By ~ 8

Author(s):

Yoshitaka Arase ◽

Koichi Shiraishi ◽

Kazuya Anzai ◽

Hirohiko Sato ◽

Erika Teramura ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Body Composition ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Liver Fat ◽

Nonalcoholic Fatty Liver

Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2020.108487 ◽

2020 ◽

Vol 170 ◽

pp. 108487

Author(s):

Wen Guo ◽

Wenjun Tian ◽

Lu Lin ◽

Xiangjin Xu

Keyword(s):

Type 2 Diabetes ◽

Liver Disease ◽

Insulin Glargine ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Obese Patients ◽

Hepatic Fat

Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial

Diabetes Care ◽

10.2337/dc17-0518 ◽

2017 ◽

Vol 40 (10) ◽

pp. 1364-1372 ◽

Cited By ~ 97

Author(s):

Daisuke Ito ◽

Satoshi Shimizu ◽

Kazuyuki Inoue ◽

Daigo Saito ◽

Morifumi Yanagisawa ◽

...

Keyword(s):

Type 2 Diabetes ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Open Label ◽

Nonalcoholic Fatty Liver

Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial

Scientific Reports ◽

10.1038/srep36783 ◽

2016 ◽

Vol 6 (1) ◽

Cited By ~ 8

Author(s):

Fangyuan Dong ◽

Yan Zhang ◽

Yiqin Huang ◽

Yiqian Wang ◽

Gansheng Zhang ◽

...

Keyword(s):

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Lifestyle Interventions ◽

Elderly Men ◽

949 Sitagliptin Versus Placebo in the Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial

Gastroenterology ◽

10.1016/s0016-5085(16)33562-4 ◽

2016 ◽

Vol 150 (4) ◽

pp. S1055

Author(s):

Jeffrey Y. Cui ◽

Len Philo ◽

Phirum Nguyen ◽

Heather Hofflich ◽

Carolyn Hernandez ◽

...

Keyword(s):

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents: The TONIC Randomized Controlled Trial

Yearbook of Pediatrics ◽

10.1016/j.yped.2011.06.073 ◽

2012 ◽

Vol 2012 ◽

pp. 458-460

Author(s):

J.A. Stockman

Keyword(s):

Liver Disease ◽

Vitamin E ◽

Fatty Liver ◽

Children And Adolescents ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: A randomized controlled trial

Scientific Reports ◽

10.1038/s41598-017-16159-x ◽

2017 ◽

Vol 7 (1) ◽

Cited By ~ 16

Author(s):

Sulin Cheng ◽

Jun Ge ◽

Can Zhao ◽

Shenglong Le ◽

Yifan Yang ◽

...

Keyword(s):

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Liver Fat ◽

Diabetic Patients ◽

Alcoholic Fatty Liver ◽

Randomized Controlled ◽

Alcoholic Fatty Liver Disease